MVM
Medicxi Ventures Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.6M | Hold |
7,464,572
| – | – | 16.75% | 2 |
|
|
2025
Q1 | $46.8M | Hold |
7,464,572
| – | – | 10.69% | 3 |
|
|
2024
Q4 | $60.6M | Hold |
7,464,572
| – | – | 11.46% | 3 |
|
|
2024
Q3 | $135M | Hold |
7,464,572
| – | – | 25.52% | 2 |
|
|
2024
Q2 | $76.9M | Hold |
7,464,572
| – | – | 22.93% | 2 |
|
|
2024
Q1 | $79.3M | Buy |
7,464,572
+3,703,703
| +98% | +$39.3M | 17.65% | 2 |
|
|
2023
Q4 | $34.3M | Hold |
3,760,869
| – | – | 11.59% | 3 |
|
|
2023
Q3 | $39M | Hold |
3,760,869
| – | – | 12.45% | 3 |
|
|
2023
Q2 | $53.9M | Buy |
3,760,869
+1,276,595
| +51% | +$18.3M | 15.09% | 3 |
|
|
2023
Q1 | $17.7M | Hold |
2,484,274
| – | – | 7.6% | 6 |
|
|
2022
Q4 | $27.9M | Hold |
2,484,274
| – | – | 11.71% | 4 |
|
|
2022
Q3 | $27.5M | Buy |
2,484,274
+33,595
| +1% | +$372K | 11.46% | 5 |
|
|
2022
Q2 | $20.7M | Buy |
2,450,679
+382,818
| +19% | +$3.23M | 8.59% | 5 |
|
|
2022
Q1 | $28.1M | Hold |
2,067,861
| – | – | 7.62% | 5 |
|
|
2021
Q4 | $40.7M | Hold |
2,067,861
| – | – | 10.18% | 5 |
|
|
2021
Q3 | $66.4M | Hold |
2,067,861
| – | – | 14.44% | 2 |
|
|
2021
Q2 | $70M | Hold |
2,067,861
| – | – | 12.54% | 2 |
|
|
2021
Q1 | $77.7M | Hold |
2,067,861
| – | – | 45.23% | 1 |
|
|
2020
Q4 | $68.7M | Hold |
2,067,861
| – | – | 39.92% | 1 |
|
|
2020
Q3 | $75.8M | Hold |
2,067,861
| – | – | 36.21% | 2 |
|
|
2020
Q2 | $68.1M | Hold |
2,067,861
| – | – | 41.83% | 1 |
|
|
2020
Q1 | $53.4M | Hold |
2,067,861
| – | – | 69.76% | 1 |
|
|
2019
Q4 | $64.4M | Buy |
+2,067,861
| New | +$64.4M | 39.46% | 2 |
|